ChartMill · Sep 18, 2026
Top stock movements in today's session.
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
NASDAQ · BCTXZ
Healthcare · Biotechnology
$0.17
Up+$0.02 (+13.53%)
Updated Sep 19, 2026, 5:22 PM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
BCTXZ closed at $0.17 after 20 trading sessions, up 62.19% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $0.1697 | $0.2647 | $0.1504 | $0.1703 | 10.74K |
| Sep 17, 2026 | $0.1376 | $0.15 | $0.1211 | $0.15 | 30.54K |
| Sep 16, 2026 | $0.1325 | $0.1485 | $0.1325 | $0.1485 | 3.85K |
| Sep 15, 2026 | $0.14 | $0.15 | $0.121 | $0.144 | 47.81K |
| Sep 14, 2026 | $0.13 | $0.1301 | $0.1114 | $0.1301 | 2.25K |
| Sep 11, 2026 | $0.12 | $0.1456 | $0.102 | $0.1441 | 188.87K |
| Sep 10, 2026 | $0.1379 | $0.14 | $0.1124 | $0.125 | 31.14K |
| Sep 9, 2026 | $0.1201 | $0.14 | $0.1019 | $0.1399 | 51.49K |
| Sep 8, 2026 | $0.169 | $0.169 | $0.14 | $0.1401 | 55.27K |
| Sep 4, 2026 | $0.19 | $0.19 | $0.1801 | $0.185 | 6.35K |
| Sep 3, 2026 | $0.191 | $0.25 | $0.1777 | $0.1895 | 21.14K |
| Sep 2, 2026 | $0.1825 | $0.25 | $0.175 | $0.2111 | 27.41K |
| Sep 1, 2026 | $0.16 | $0.20 | $0.1501 | $0.187 | 17.05K |
| Aug 31, 2026 | $0.1644 | $0.1699 | $0.1311 | $0.15 | 20.82K |
| Aug 28, 2026 | $0.15 | $0.156 | $0.1259 | $0.135 | 13.36K |
| Aug 27, 2026 | $0.1202 | $0.1673 | $0.1202 | $0.1202 | 14.38K |
| Aug 26, 2026 | $0.12 | $0.15 | $0.12 | $0.1254 | 39.92K |
| Aug 25, 2026 | $0.121 | $0.13 | $0.11 | $0.115 | 20.15K |
| Aug 24, 2026 | $0.12 | $0.14 | $0.1059 | $0.11 | 34.64K |
| Aug 21, 2026 | $0.112 | $0.1731 | $0.105 | $0.105 | 37.64K |
The latest Smart Investors Daily articles mentioning BCTXZ.


The latest Smart Investors Daily articles mentioning BCTXZ.
No results
No recent SID articles mention BCTXZ.
BCTXZ research
Filterable reporting and market headlines.
Filters are reflected in the page URL for sharing and back-button support.
3 matching articles.
ChartMill · Sep 18, 2026
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
Yahoo · Sep 14, 2026
Independent DSMB reports no safety concerns to date and recommends continuing BriaCell's pivotal Phase 3 study of Bria-IMT™ plus an immune checkpoint inhibitorSeventh consecutive positive DSMB recommendation reinforces the favorable safety and tolerability of BriaCell's novel immunotherapy approachPhase 3 study is being conducted under FDA Fast Track designation, underscoring the substantial unmet need in metastatic breast cancer PHILADELPHIA and VANCOUVER, British Columbia, Sept. 14, 2026 (GLOB
ChartMill · Sep 18, 2026
Let's have a look at the gap up and gap down stocks in today's session.